Neutral stance maintained as multi-signal technical deterioration awaits 200-SMA test; Q3 2026 earnings (~mid-October) is the resolution catalyst
The HOLD rating reflects an asymmetric setup where multi-signal technical deterioration (10-EMA, 50-SMA, MACD most negative since March 2026, Bollinger lower band breach) is real but the 200-SMA at $1,048—the regime-change line—has not been tested. Forward valuation is fair-with-optionality, not mispriced in either direction; 93% odds of no 2026 rate cuts gate off the multiple-expansion lever. Q3 earnings is the resolution catalyst that converts HOLD into either Buy or Sell more cleanly than pre-emptive positioning can.
| Position | Action |
|---|---|
| Current position | Maintain at 70-75% of benchmark weight (per 9/8 trim already executed) |
| New longs | Do not initiate |
| Additional trim | Do not compound |
| Fresh capital deployment | Defer until after Q3 2026 earnings (~mid-October) |
| $1,050 add | Condition on 200-SMA reclaim with reversal confirmation |
BlackRock is a secular compounder with PEG < 1 at 16.67x Forward P/E, accelerating earnings momentum already underway (Q1 +35%, Q2 +20% YoY), $5B+ annual capital returns, and a technical gift at 200-SMA support—making the current setup a buy-the-dip opportunity rather than a wait-and-see HOLD.
| Indicator | Value | Signal |
|---|---|---|
| 10-EMA | $1,116.39 | bearish |
| 50-SMA | $1,091.74 | bearish |
| 200-SMA | $1,048.30 | bullish |
| RSI (14) | 37.11 | bearish |
| MACD | -0.85 | bearish |
| MACD Signal | 11.36 | bearish |
| MACD Histogram | -12.21 | bearish |
| Bollinger Lower Band | $1,084.65 | bearish |
| Bollinger Middle Band (20-SMA) | $1,141.47 | bearish |
| ATR (14) | $23.11 | neutral |
| VWMA |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close >$1,116 on volume >1.0M
Then: Upgrade to Overweight
↩ rebuts: “Bear's 'premium valuation' flag based on TTM P/E of 25.69x”
EV: Target $1,176 on trend resumption (from current ~$1,072) · concedes: CLARITY Act passage odds collapsed from 80% to 14%—though framed as nonevent since crypto AUM is already in bank; Franklin alternatives AUM crossing $300B represents real competitive pressure; TTM P/E is elevated at 25.69x due to GIP integration, but Forward P/E of 16.67x captures earnings recovery already underway
BlackRock's "buy the dip" trade is asymmetrically risky to the downside given broken technical support, margin compression despite revenue growth, elevated goodwill impairment risk, and no near-term macro catalyst—making HOLD or UNDERWEIGHT the appropriate stance until either technicals confirm stabilization or a deeper drawdown improves risk/reward.
EV: -$196 (approximately -18% downside) · concedes: BlackRock is a great company and a compounder with a fortress balance sheet, generating $5B+ in capital returns; The franchise is real and the 21,000 employees and iShares franchise are genuine assets; This is not a permanent impairment to the business — only to P&L if bought at the wrong time
→ vs conservative: Stay-away thesis misses that declining volume, oversold RSI at 37, and MACD histogram at negative 12 historically mark bottoms not tops for BLK; a PEG under 1 on a 10%+ revenue grower is mispriced not fairly valued
→ vs neutral: Waiting for confirmed breakout above 1,116 on volume risks missing the move if BLK chops between 1,048 and 1,116 for six weeks while rate-cut catalyst never arrives; the aggressive position is to hold benchmark weight and queue buy at 1,050
| $1,138.66 |
| neutral |
| Current Close | $1,072.03 | bearish |
| Intraday Low | $1,071.24 | bearish |
Support: 1048.3 · 1084.65 · 1072.03 · 1091.74 | Resistance: 1116.39 · 1141.47 · 1166.62 · 1176.8
BlackRock (BLK) exhibits a classic mid-trend pullback with short-term bearish technicals conflicting with intact long-term bullish structure. Price has decisively broken below the 10-EMA and 50-SMA while testing the lower Bollinger Band intraday, but remains above the critical 200-SMA at $1,048.30. RSI approaching oversold without yet triggering and MACD histogram at -12.21 indicate deteriorating momentum, though the orderly volume profile (VWMA declining but not on panic selling) and 1-ATR stop coinciding precisely with the 200-SMA ($1,048.92 vs $1,048.30) create a high-conviction support zone. The report advises defensive positioning—avoid initiating new longs at current levels, avoid shorts given 200-SMA proximity, and trail stops to $1,048 for existing holders—framing this as a potential mean reversion entry rather than a confirmed trend reversal.
Market Cap
$174.18 billion
Beta
1.429
Current Price (implied)
~$1,071.88
52-Week Range
$917.39 – $1,219.94
50-Day Moving Average
$1,094.69
200-Day Moving Average
$1,059.64
Dividend Yield
2.09%
P/E (TTM)
25.69x
Forward P/E
16.67x
PEG Ratio
0.94
Price/Book
2.88x
EPS (TTM)
$41.73
Forward EPS
$64.31
Revenue 2022
$17.87B
Revenue 2023
$17.86B
Revenue 2024
$20.41B
Revenue 2025
$24.22B
Revenue CAGR 2022→2025
~10.7%
Gross Profit 2022
$8.68B
Gross Profit 2023
$8.58B
Gross Profit 2024
$10.09B
Gross Profit 2025
$11.31B
Gross Profit CAGR 2022→2025
~9.2%
Operating Income 2022
$6.48B
Operating Income 2023
$6.34B
Operating Income 2024
$7.54B
Operating Income 2025
$7.91B
Operating Income CAGR 2022→2025
~6.8%
EBITDA 2022
$6.92B
EBITDA 2023
$7.87B
EBITDA 2024
$9.36B
EBITDA 2025
$9.36B
Adjusted (Normalized) EBITDA 2025
$9.48B
EBITDA CAGR 2022→2025
~10.6%
Net Income 2022
$5.18B
Net Income 2023
$5.50B
Net Income 2024
$6.37B
Net Income 2025
$5.55B
Net Income CAGR 2022→2025
~2.4%
Diluted EPS 2022
$33.97
Diluted EPS 2023
$36.51
Diluted EPS 2024
$42.01
Diluted EPS 2025
$35.31
Diluted EPS CAGR 2022→2025
~1.3%
Net Margin 2022
~29.0%
Net Margin 2023
~30.8%
Net Margin 2024
~31.2%
Net Margin 2025
~22.9%
Restructuring / M&A Charges 2025
$759M
Cost of Revenue 2024
$10.32B
Cost of Revenue 2025
$12.96B
Q2 2025 Revenue
$5.42B
Q2 2025 Net Income
$1.59B
Q2 2025 Diluted EPS
$10.19
Q3 2025 Revenue
$6.51B
Q3 2025 Net Income
$1.32B
Q3 2025 Diluted EPS
$8.43
Q4 2025 Revenue
$7.01B
Q4 2025 Net Income
$1.13B
Q4 2025 Diluted EPS
$7.16
Q1 2026 Revenue
$6.70B
Q1 2026 Net Income
$2.21B
Q1 2026 Diluted EPS
$14.06
Q2 2026 Revenue
$7.08B
Q2 2026 Net Income
$1.91B
Q2 2026 Diluted EPS
$12.19
H1 2026 Revenue
$13.78B
Revenue (TTM)
$27.30B
EBITDA (TTM)
$11.12B
Net Income (TTM)
$6.58B
Gross Margin
~47.2%
Operating Margin
35.08%
Net Profit Margin
24.09%
ROE
12.28%
ROA
3.74%
Total Assets 2022
$117.6B
Total Assets 2023
$123.2B
Total Assets 2024
$138.6B
Total Assets 2025
$170.0B
Total Assets Q2 2026
$175.9B
Total Equity 2022
$37.7B
Total Equity 2023
$39.3B
Total Equity 2024
$47.5B
Total Equity 2025
$55.9B
Total Equity Q2 2026
$57.6B
Total Debt 2022
$8.5B
Total Debt 2023
$9.7B
Total Debt 2024
$14.2B
Total Debt 2025
$15.0B
Total Debt Q2 2026
$15.0B
Cash & Equivalents 2022
$7.4B
Cash & Equivalents 2023
$8.7B
Cash & Equivalents 2024
$12.8B
Cash & Equivalents 2025
$11.5B
Cash & Equivalents Q2 2026
$10.5B
Goodwill 2022
$15.3B
Goodwill 2023
$15.5B
Goodwill 2024
$25.9B
Goodwill 2025
$35.3B
Goodwill Q2 2026
$35.2B
Net Debt 2025
$1.3B
Net Debt Q2 2026
$2.3B
Debt/Equity Ratio
~26%
Current Ratio
2.45x
Goodwill + Intangibles
~$62.6B
Tangible Book Value 2025
-$7.4B
Operating Cash Flow 2022
$4.96B
Operating Cash Flow 2023
$4.17B
Operating Cash Flow 2024
$4.96B
Operating Cash Flow 2025
$3.93B
CapEx 2022
($0.53B)
CapEx 2023
($0.34B)
CapEx 2024
($0.26B)
CapEx 2025
($0.38B)
Free Cash Flow 2022
$4.42B
Free Cash Flow 2023
$3.82B
Free Cash Flow 2024
$4.70B
Free Cash Flow 2025
$3.55B
Free Cash Flow (TTM)
$7.58B
Dividends Paid 2022
$2.99B
Dividends Paid 2023
$3.04B
Dividends Paid 2024
$3.10B
Dividends Paid 2025
$3.35B
Buybacks 2022
$2.33B
Buybacks 2023
$1.88B
Buybacks 2024
$1.93B
Buybacks 2025
$1.95B
Total Returned to Shareholders 2022
$5.32B
Total Returned to Shareholders 2023
$4.92B
Total Returned to Shareholders 2024
$5.03B
Total Returned to Shareholders 2025
$5.30B
Business Acquisitions 2023
$0.19B
Business Acquisitions 2024
$2.94B
Business Acquisitions 2025
$3.50B
Global Infrastructure Partners Acquisition
$3.0B
52-Week High
$1,219.94
52-Week Low
$917.39
Strengths
Concerns
BLACKROCK INC (BLK) - NYSE: Financial Services / Asset Management | Rating: HOLD | BlackRock operates the world's largest asset management franchise with $175.9B in total assets, commanding industry-leading operating margins (35.1%) and net margins (24.1%), driven by its dominant iShares ETF platform and expanding alternatives business through the landmark $3B Global Infrastructure Partners acquisition. Revenue grew 18.6% YoY to $24.22B in FY2025 (+10.7% CAGR 2022-2025), though net income compressed to $5.55B due to $759M restructuring charges tied to GIP integration; adjusted EBITDA actually rose 7.3% to $9.48B. The balance sheet is conservatively leveraged with only $2.3B net debt against $57.6B equity, though $35.2B in goodwill (~36% of assets) creates impairment risk. Q1-Q2 2026 shows strong recovery with EPS of $14.06 (+35% YoY) and $12.19 (+20% YoY), supporting the $64.31 forward EPS estimate. Capital returns are exceptional with $5.30B returned to shareholders in 2025 (dividends + buybacks), consistently exceeding free cash flow generation. Trading at $1,071.88 with Forward P/E of 16.67x near 52-week highs; upside to $1,220 resistance limited without pullback to 200-DMA (~$1,060) or confirmed breakout on volume.
Macro: Soft-landing consensus intact (8% recession probability) with disinflationary backdrop (8% odds of inflation >5%, 5% odds of inflation >6%). Hawkish Fed pricing: 93% probability of zero 2026 rate cuts (+4.0pp week-over-week). CLARITY Act crypto-legitimization catalyst has collapsed to ~14% from ~80-90% in February.